HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma - Wikidata - awgldk - TriplyDB

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

http://www.wikidata.org/entity/Q37295329

about

Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells.Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network.N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry.Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer.HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma Overview of advances in vasculogenic mimicry - a potential target for tumor therapy

P2860

Q26773795-7DA145B9-528C-45A8-9BF0-0DDEB1984D3D Q34685016-A161C6EF-F1B6-4308-AEE6-D3C99C269E6B Q34750633-9094C057-B23F-4BFE-AEE0-6B11FA24E016 Q35741127-4BC72842-F143-4BF1-84F6-C52E88021A63 Q35793839-EAAB55CE-E75C-4481-B866-AB991B916B84 Q36046327-5222F074-8491-4CBE-98F2-599D08C5754D Q36546746-F556B469-CD45-4C4D-A6E7-C06228F48DCC Q36733548-7A354A87-BE5E-4689-9F67-BE895A7A5D56 Q37020145-24504DFB-E54B-4396-8449-CB72B79B529B Q38281325-9EAF0ABD-DE0A-4617-A148-C0D0CAE55CDA Q38921577-2E2A65E5-426B-4FCB-88AA-A5F01EB792C2 Q39188509-189B4497-6E3D-433D-B40D-3A022C4A11A7 Q41346466-C263DEC7-282F-4111-BCFC-91944EBA5A1F Q41471311-D736BC24-8D8B-4B2C-A6AE-86A5E3B8C58E Q41551956-EFEF9453-5CA9-4C23-B929-9431E40A7EAF Q42638789-AFAF6BE2-C893-4F09-AEDB-817BA2C6CF09 Q45938628-90EA84DB-A3B0-466E-B48D-BC21E09FD4F9 Q58779506-0FD03588-F3A4-4AC7-95FA-6C6F2753980C Q58803491-95A260BE-D607-4BF3-BD24-65AE6BF97AB0

P2860

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

http://www.wikidata.org/entity/Q37295329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

@en

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma.

@nl

type

label

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

@en

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma.

@nl

prefLabel

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

@en

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma.

@nl

P1433

Q37295329-CAB8DC53-D3D8-41C3-BB5B-7793D9C42718

P1476

Q37295329-6162C69A-C2F7-426A-81BE-D86E0338B4FE

P2093

Q37295329-302B88E8-445D-435B-8146-B1A65B1EDB41

Q37295329-48A7C570-2BC1-44E6-B3D3-A5BA245B123A

Q37295329-55F58F6D-BDC0-4900-826B-23477BE39165

Q37295329-77FBEBA4-08AE-497F-BA4C-DCE469F5010B

Q37295329-7FD8B5C4-7044-4D06-82FB-D5CA4B0B7650

Q37295329-84511038-45D6-4602-9477-331D96E10FA8

Q37295329-8A4A4AC3-34B9-4AB3-8550-1B5957C837B5

Q37295329-8D610659-8307-4417-96CA-53CC655F0295

Q37295329-B8F36677-680B-454C-B96F-7346B7BF7C7F

Q37295329-F515A23C-7E1B-4BD0-9901-1FD378A33BC2

P2860

Q37295329-1EAB86D8-511F-41C4-B0DC-C722CB5223A2

Q37295329-2833D497-241D-4D9C-9DD3-BE69238DF014

Q37295329-2D7AFBDE-7861-4828-A2F7-73CD00963505

Q37295329-462D7B9F-5C50-4CAF-A44C-7DBC3DACCCBA

Q37295329-498C7B29-283B-47DB-8E3D-DB29700A3B42

Q37295329-5A79C587-6C64-4093-8726-D4E3052516A9

Q37295329-633EF08E-F5A5-4C4B-8B62-0E8AFDF27828

Q37295329-6A819523-E0C0-4D32-A243-7A78F55F03B9

Q37295329-70191DC9-26C3-4600-A4E7-320713C9665C

Q37295329-73D19C38-93C0-4516-9169-9F2DFEF42CFE

P304

Q37295329-6577C809-CD13-42CB-B1A5-D7137B3C03F4

P31

Q37295329-D507B7EE-70EE-48D7-8FA0-378C031E6E36

P356

Q37295329-4AEEB79C-0CE8-4D5E-A7CD-6E0C8B8BECC7

P433

Q37295329-7C323091-EE18-4088-81DD-DACF0888A27D

P478

Q37295329-A1452681-7BD5-45D6-93FB-FA90CFE489A6

P577

Q37295329-B4A08F96-2CDC-4F53-BB56-CC89EAD8D2DA

P5875

Q37295329-B8DC5167-0183-4362-A2CF-9B660091D92D

P698

Q37295329-BA93EC8F-7057-4195-9F01-9EE09BBAC3F2

P932

Q37295329-5E8FF105-A511-4B58-BBD7-925FCFA21593

P356

J.1582-4934.2012.01653.X

P1433

Journal of Cellular and Molecular Medicine

P1476

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

@en

P2093

Baocun Sun

http://www.w3.org/2001/XMLSchema#string

Jiadong Chi

http://www.w3.org/2001/XMLSchema#string

Nan Zhao

http://www.w3.org/2001/XMLSchema#string

Ning Liu

http://www.w3.org/2001/XMLSchema#string

Qiang Gu

http://www.w3.org/2001/XMLSchema#string

Ran Sun

http://www.w3.org/2001/XMLSchema#string

Tieju Liu

http://www.w3.org/2001/XMLSchema#string

Xiulan Zhao

http://www.w3.org/2001/XMLSchema#string

Xueyi Dong

http://www.w3.org/2001/XMLSchema#string

Yuemei Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Vasculogenic mimicry: current status and future prospects.

Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies.

Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis.

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Adjuvant trastuzumab in HER2-positive breast cancer.

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

Targeting cancer stem cells to modulate alternative vascularization mechanisms.

P304

116-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2012.01653.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234031114

http://www.w3.org/2001/XMLSchema#string

P698

23279650

http://www.w3.org/2001/XMLSchema#string

P932

3823141

http://www.w3.org/2001/XMLSchema#string